Wellington Management Group LLP Passage Bio, Inc. Transaction History

Wellington Management Group LLP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$2.66 - $6.49 $1,872 - $4,568	704 Added 0.3%	238,720 $740,000
Q4 2021 Feb 11, 2022	SELL	$6.24 - $10.2 $1.14 Million - $1.87 Million	-183,162 Reduced 43.49%	238,016 $1.51 Million
Q3 2021 Nov 15, 2021	BUY	$9.73 - $15.52 $336,658 - $536,992	34,600 Added 8.95%	421,178 $4.2 Million
Q2 2021 Aug 16, 2021	BUY	$12.44 - $19.45 $3.44 Million - $5.39 Million	276,878 Added 252.4%	386,578 $5.12 Million
Q1 2021 May 17, 2021	BUY	$16.24 - $29.83 $537,544 - $987,373	33,100 Added 43.21%	109,700 $1.92 Million
Q3 2020 Nov 16, 2020	SELL	$12.39 - $26.15 $153,462 - $323,893	-12,386 Reduced 13.92%	76,600 $1 Million
Q2 2020 Aug 14, 2020	SELL	$14.59 - $36.07 $569,622 - $1.41 Million	-39,042 Reduced 30.49%	88,986 $2.43 Million
Q1 2020 May 14, 2020	BUY	$8.86 - $22.2 $1.13 Million - $2.84 Million	128,028 New	128,028 $2.02 Million

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $25.6M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.